President Biden is bringing a number of 340B policy experts on board to his team. Yesterday, he formally nominated Andrea Palm, most recently Wisconsin’s health secretary-designate, to be U.S. Deputy Secretary of Health and Human Services (HHS). Palm would be
…Category: Regulatory
The U.S. Health Resources and Services Administration (HRSA), in light of the declared public health emergency in Texas, is letting eligible health care providers there enroll immediately in the 340B drug pricing program instead of waiting for the next normal
…
The Biden administration should reverse “harmful Trump administration policies” that “undermined the 340B program and contravened Congress’ intent,” the group America’s Essential Hospitals advised President Biden in a letter earlier this month.
America’s Essential Hospitals’ Feb. 10 letter said
…
Two U.S. Senate committees have scheduled hearings next week on President Biden’s nomination of California Attorney General Xavier Becerra to be the next U.S. Health and Human Services (HHS) Secretary. In December, Becerra helped spearhead a bipartisan letter of
…
Several news organizations report that the Biden administration will nominate former federal executive and legislative branch health policy official Chiquita Brooks-LaSure to serve as Administrator of the Center for Medicare & Medicaid Services (CMS). The White House had not announced
…Generic liquid drug manufacturer Pharmaceutical Associates, Inc. (PAI), has notified 340B covered entities on the U.S. Health Resources and Services Administration (HRSA) website about 340B overcharges and potential credit/rebill repayments regarding all of its products covering the first through third
…The U.S. Health Resources and Services Administration (HRSA) is “ramping up” its work with the Biden administration “and bringing forth the key issues and concerns of” the 340B program, Rear Adm. Krista Pedley, the program’s director, said today in a
…
A Pulitzer Prize-winning journalism website that fact-checks politicians’ claims has waded into the controversy over whether President Biden raised insulin prices by freezing a 340B-related Trump administration regulation.
On Feb. 11, the Poynter Institute’s PolitiFact site rated U.S. Senate
…
Drug manufacturer Glaxo Smith Kline (GSK) yesterday notified 340B covered entities on the U.S. Health Resources and Services Administration (HRSA) website that it is offering refunds for overcharges on about two dozen NDCs during the first quarter of 2019.
In
…